4 The Guideline Development Group, National Collaborating Centre and NICE project team, and declarations of interests

4 The Guideline Development Group, National Collaborating Centre and NICE project team, and declarations of interests

4.1 Guideline Development Group

The Guideline Development Group members listed are those for the 2015 update. For the composition of the previous Guideline Development Group, see the full guideline.

Stephanie Amiel
Professor of Diabetic Medicine, King's College London

Augustin Brooks
Consultant Diabetologist, Bournemouth Hospital

Arthur Durrant
Patient member

Michael Flynn
Consultant Physician, Kent and Canterbury Hospital

Roger Gadsby
Visiting Professor, Institute of Diabetes in Older People, University of Bedfordshire; GP; and Principal Teaching Fellow, University of Warwick

Peter Hammond
Consultant Physician, Harrogate District Hospital

Michael Kendall
Patient member

Vibhuti Mistry
Lead Diabetes and Obesity Dietitian, Homerton University NHS Foundation Trust

Henrietta Mulnier
Lecturer in Diabetes Nursing, King's College London

Victoria Ruszala
Specialist Pharmacist, Diabetes and Endocrinology, North Bristol NHS Trust

Stuart Smellie
Consultant in Chemical Pathology, Durham and Darlington NHS Foundation Trust

Perdy van den Berg
Clinical Lead, Oxfordshire Diabetes Service

4.2 National Clinical Guideline Centre

Jill Cobb
Information Scientist

Dalia Dawoud
Health Economist

Bernard Higgins
Clinical Director

Elisabetta Fenu
Health Economics Lead

Bethany King
Document Editor/Process Assistant

Rachel O'Mahony
Senior Research Fellow

Nancy Pursey
Senior Project Manager

4.3 NICE project team

Christine Carson
Guideline Lead

Phil Alderson
Clinical Adviser

Clifford Middleton
Guideline Commissioning Manager

Jennifer Wells
Guideline Coordinator

Nichole Taske
Technical Lead

Bhash Naidoo
Health Economist

Lyn Knott
Editor

4.4 Declarations of interests

The following members of the Guideline Development Group made declarations of interests. All other members of the Group stated that they had no interests to declare. The conflicts of interest policy (2007) was followed until September 2014, when an updated policy was published.

Committee member

Interest declared

Type of interest

Decision taken

Stephanie Amiel (Chair)

Co‑head of a Clinical Academic Group and an academic division at King's College London and King's College Hospital

Non‑personal, specific, pecuniary

Declare and participate

Stephanie Amiel (Chair)

Member of the Juvenile Diabetes Research Foundation and Diabetes UK advisory boards

Personal, specific, non‑pecuniary

Declare and participate

Stephanie Amiel (Chair)

Member of the Diabetes and Wellness Foundation editorial board

Personal, specific, non‑pecuniary

Declare and participate

Stephanie Amiel (Chair)

Academic representative of the Executive Committee of the Association of British Clinical Diabetologists

Personal, specific, non‑pecuniary

Declare and participate

Stephanie Amiel (Chair)

Chairman of the National dose adjustment for normal eating (DAFNE) executive

Personal, specific, non‑pecuniary

Declare and participate

Stephanie Amiel (Chair)

Member of the International Hypoglycaemia Study Group, run and funded by the Six Degrees Academy, which is supported by multiple sponsors including Novo Nordisk

Personal, specific, non‑pecuniary

Declare and participate

Stephanie Amiel (Chair)

Chairman of the EFSD/China Diabetes Society/Lilly Programme

Non‑personal, specific, pecuniary

Declare and participate

Stephanie Amiel (Chair)

Editor of the International Diabetes Federation's journal, Diabetes Voice

Non‑personal, specific, pecuniary

Declare and participate

Stephanie Amiel (Chair)

Member of the Juvenile Diabetes Research Foundations' international scientific advisory board

Non‑personal, specific, pecuniary

Declare and participate

Arthur Durrant

Chair of the Sheffield Teaching Hospitals' Lay Panel for Diabetes & Endocrinology Research

Personal, specific, non‑pecuniary

Declare and participate

Roger Gadsby

Member of the MSD (sitagliptin), NovoNordisk (insulin degludec) and Janssen (canagliflozin) advisory boards

Personal, specific, pecuniary

Declare and withdraw from discussions of all types of insulin

Roger Gadsby

Part of the team that developed Warwick Diabetes Care (WDC)

Non‑personal, specific, pecuniary

Declare and participate

Roger Gadsby

Chairman of the Trustees of Pregnancy Sickness Support Trust (Registered Charity No. 1094788)

Non‑personal, specific, pecuniary

Declare and participate

Roger Gadsby

Member of the NovoNordisk Diabetes Primary Care Advisory Board for Degludec

Personal, specific, pecuniary

Declare and withdraw from discussions on insulin

Peter Hammond

Part of the team that delivered a video‑workshop on diabetes and pregnancy Medtronic to various centres in Eastern Europe

Personal, specific, non‑pecuniary

Declare and participate

Henrietta Mulnier

Member of the Novo Nordisk nursing advisory board

Personal, specific, pecuniary

Declare and withdraw from discussions about insulin and needle lengths

Henrietta Mulnier

Part of the team that developed a new education and support programme for Novo Nordisk

Personal, specific, non‑pecuniary

Declare and participate at chair's discretion (pending expiry of prior conflict for insulin)

Victoria Ruszala

Pharmacy lead for the NHS England Endocrinology clinical reference group

Personal, non‑specific, non‑pecuniary

Declare and participate

Victoria Ruszala

Member of the Sanofi advisory board

Personal, specific, pecuniary

Declare and withdraw from discussions on insulin

Stuart Smellie

Clinical Director of the Association of Clinical Biochemists

Personal, non‑specific, pecuniary

Declare and participate

Stuart Smellie

Vice President of the Association of Clinical Pathologists

Personal, non‑specific, pecuniary

Declare and participate

  • National Institute for Health and Care Excellence (NICE)